Assignee
REPROS THERAPEUTICS INC
US·17 granted patents·19 pending applications·88 citations·filing 2002–2018
Top patents by PatentIndex Score
36 records- 0196US8735381B2Progesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer, etcREPROS THERAPEUTICS INC·Filed 2013·Granted May 27, 2014·56 cites·9 claims
- 0290US9914696B2Clomiphene synthesis using a single solventREPROS THERAPEUTICS INC·Filed 2015·Granted Mar 13, 2018·4 cites·16 claims
- 0386US10555900B2Formulations and methods for vaginal delivery of antiprogenstinsREPROS THERAPEUTICS INC·Filed 2018·Granted Feb 11, 2020·4 cites·17 claims
- 0479US10064815B2Formulations and methods for vaginal delivery of antiprogestinsREPROS THERAPEUTICS INC·Filed 2015·Granted Sep 4, 2018·2 cites·15 claims
- 0578US7368480B2Methods and compositions with trans-clomipheneREPROS THERAPEUTICS INC·Filed 2003·Granted May 6, 2008·8 cites·7 claims
- 0674US7759360B2Methods and materials for the treatment of testosterone deficiency in menREPROS THERAPEUTICS INC·Filed 2002·Granted Jul 20, 2010·4 cites·7 claims
- 0773US8377991B2Trans-clomiphene for metabolic syndromeREPROS THERAPEUTICS INC·Filed 2011·Granted Feb 19, 2013·5 cites·8 claims
- 0872US9545411B2Methods and compositions for treating progesterone-dependent conditionsREPROS THERAPEUTICS INC·Filed 2013·Granted Jan 17, 2017·2 cites·18 claims
- 0968US8372887B2Trans-clomiphene for metabolic syndromeREPROS THERAPEUTICS INC·Filed 2008·Granted Feb 12, 2013·2 cites·8 claims
- 1067US7173064B2Methods and compositions with trans-clomiphene for treating wasting and lipodystrophyREPROS THERAPEUTICS INC·Filed 2003·Granted Feb 6, 2007·1 cites·7 claims
- 1164US7737185B2Methods and compositions with trans-clomipheneREPROS THERAPEUTICS INC·Filed 2007·Granted Jun 15, 2010·0 cites·7 claims
- 1263US10561624B2Methods and materials for the treatment of testosterone deficiency in menREPROS THERAPEUTICS INC·Filed 2016·Granted Feb 18, 2020·0 cites·9 claims
- 1363US2014093560A1Methods and materials for the treatment of testosterone deficiency in menREPROS THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1461US9616074B2Compositions and methods for suppressing endometrial proliferationREPROS THERAPEUTICS INC·Filed 2014·Granted Apr 11, 2017·0 cites·10 claims
- 1558US2011053900A1Progesterone antagonists such as cdb-4124 in the treatment of breast cancerREPROS THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1657US7776899B2Methods for treatment of erectile dysfunctionREPROS THERAPEUTICS INC·Filed 2003·Granted Aug 17, 2010·0 cites·13 claims
- 1756US2015265553A1Methods and Materials for the Treatment of Testosterone Deficiency in MenREPROS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1854US2019127413A1Compositions and Methods for Non-Toxic Delivery of AntiprogestinsREPROS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1953US2017189421A1Compositions and Methods for Suppressing Endometrial ProliferationREPROS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2052US2016346295A1Selective Estrogen Receptor Modulators With Short Half-Lives and Uses ThereofREPROS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2151US2014343022A1Progesterone Antagonists such as CDB-4124 in the Treatment of Breast CancerREPROS THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2250US2016038506A1Selective Estrogen Receptor Modulators With Short Half-Lives and Uses ThereofREPROS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2349US9687458B2Trans-clomiphene for use in cancer therapyREPROS THERAPEUTICS INC·Filed 2013·Granted Jun 27, 2017·0 cites·18 claims
- 2449US2010311785A1Combination Therapy For Modulating The Human Sexual ResponseREPROS THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 2548US2013018027A1Compositions and methods for non-toxic delivery of antiprogestinsREPROS THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 2648US2009118253A1Compositions and methods for treating dysfunctional uterine bleedingREPROS THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 2748US2020069702A1Oral pharmaceutical compositions comprising an unmicronized selective progesterone receptor as active agentREPROS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2845US2015203526A1Novel 19-nor-steroids and their use for treating progesterone- dependent conditionsREPROS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2945US2008306035A1Methods and Compositions for Treating Female Infertility Using ClomipheneREPROS THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3044US10328022B2Formulations and methods for vaginal delivery of antiprogestinsREPROS THERAPEUTICS INC·Filed 2013·Granted Jun 25, 2019·0 cites·6 claims
- 3144US2009215906A1Methods and materials with trans-clomiphene for the treatment of male infertilityREPROS THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3242US2015202167A1Trans-Clomiphene Formulations and Uses ThereofREPROS THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3340US2015031656A1Combination therapy for treating androgen deficiencyREPROS THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3439US9616034B2Trans-clomiphene and its analogues as agents that increase bone mineral densityREPROS THERAPEUTICS INC·Filed 2014·Granted Apr 11, 2017·0 cites·12 claims
- 3537US2019008804A1Trans-Clomiphene and Progesterone Receptor Antagonist Combination Therapy for Treating Hormone-Dependent ConditionsREPROS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3632US2020030259A1Antiestrogens and/or Aromatase Inhibitors for Use in Treating Obesity and Related SymptomsREPROS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when REPROS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →